HK Stock Market Move | PRADA (01913) rose by over 6% in the afternoon, and it is rumored that PRADA is considering acquiring Valentino. Several major banks are optimistic about the company's growth prospects.
Prada (01913) rose over 6% in the afternoon, up 5.64% as of press time, at 62.7 Hong Kong dollars, with a turnover of 92.4929 million Hong Kong dollars.
PRADA (01913) rose more than 6% in the afternoon, rising 5.64% to HK$62.7 at the time of writing, with a turnover of HK$92.49 million.
On the news front, according to media reports, PRADA is evaluating the possibility of acquiring the Italian luxury fashion brand Versace and is working with advisors to consider potential transactions. Citigroup has provided advice to PRADA. Reports indicate that since mid-December last year, there have been increasing rumors that Capri is preparing to sell the Versace and Jimmy Choo brands and has commissioned Barclays to research possible sales.
In addition, a recent research report by Morgan Stanley pointed out that the growth potential of the Prada brand in the foreseeable future remains strong. The bank maintained a "hold" rating for PRADA, with a target price raised from HK$67 to HK$69. The bank continues to expect PRADA's profit performance to outperform the market, citing the group's positive growth prospects, mainly benefiting from the strong performance of its subsidiary brand Miu Miu. UBS, on the other hand, has expressed that there is potential for the company's fundamentals to be reassessed, reiterating a "buy" rating and raising the target price from HK$74 to HK$77.
Related Articles

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!

JP Morgan: AI demand "bursting" advanced process Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) Q1 gross margin may exceed expectations.
Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!

JP Morgan: AI demand "bursting" advanced process Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) Q1 gross margin may exceed expectations.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


